Replies to post #119207 on Biotech Values

[DewDiligence]

I haven’t seen anything re BMY—could be a data error.

[dav1234]

17:59:10 NYSE Reviewing Possible Bad After-Hours Trades In Many Stocks

[dewophile]

$45 sounds like a fair buyout price for BMY if you ask me:)
i'm being serious
i mean if SGP could go for 41B and whose vaunted "5 star" pipeline turned into a bunch of duds BMY should be worth way more than that by now given they've been hitting on all cylinders

[DewDiligence]

Someone actually lost significant money in yesterday’s AH screw-up:

http://online.wsj.com/article/SB10001424052748703922804576301133002321042.html

The surge in prices was caused when a brokerage firm submitted an erroneous order to Nasdaq, exchange spokesman Frank DeMaria said Tuesday. Nasdaq noticed the unusually high prices in many of the stocks and notified the brokerage, which filed to break the trades in exchange for paying a 30% penalty, Mr. DeMaria said. Nasdaq declined to disclose which brokerage had submitted the bad order.

The affected stocks were dominated by major health-care companies, including insurers Aetna Inc. and Humana Inc., drug makers Bristol-Myers Squibb Co., Pfizer Inc. and Eli Lilly & Co. and the consumer-products giant Johnson & Johnson.